These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


329 related items for PubMed ID: 33039957

  • 1. Upregulation of FoxO3a expression through PI3K/Akt pathway attenuates the progression of lupus nephritis in MRL/lpr mice.
    Zhao C, Gu Y, Chen L, Su X.
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107027. PubMed ID: 33039957
    [Abstract] [Full Text] [Related]

  • 2. Procyanidin B2 prevents lupus nephritis development in mice by inhibiting NLRP3 inflammasome activation.
    He J, Sun M, Tian S.
    Innate Immun; 2018 Jul; 24(5):307-315. PubMed ID: 29874961
    [Abstract] [Full Text] [Related]

  • 3. Complement factor B inhibitor LNP023 improves lupus nephritis in MRL/lpr mice.
    Chen K, Deng Y, Shang S, Tang L, Li Q, Bai X, Chen X.
    Biomed Pharmacother; 2022 Sep; 153():113433. PubMed ID: 36076550
    [Abstract] [Full Text] [Related]

  • 4. Icariin alleviates murine lupus nephritis via inhibiting NF-κB activation pathway and NLRP3 inflammasome.
    Su B, Ye H, You X, Ni H, Chen X, Li L.
    Life Sci; 2018 Sep 01; 208():26-32. PubMed ID: 30146016
    [Abstract] [Full Text] [Related]

  • 5. Sophocarpine attenuates murine lupus nephritis via inhibiting NLRP3 inflammasome and NF-κB activation.
    Li X, Wang M, Hong H, Luo C, Liu Z, Yang R.
    Immunol Res; 2018 Aug 01; 66(4):521-527. PubMed ID: 30047025
    [Abstract] [Full Text] [Related]

  • 6. Activation-induced deaminase-deficient MRL/lpr mice secrete high levels of protective antibodies against lupus nephritis.
    Jiang C, Zhao ML, Scearce RM, Diaz M.
    Arthritis Rheum; 2011 Apr 01; 63(4):1086-96. PubMed ID: 21225690
    [Abstract] [Full Text] [Related]

  • 7. The Atypical Antipsychotic Agent, Clozapine, Protects Against Corticosterone-Induced Death of PC12 Cells by Regulating the Akt/FoxO3a Signaling Pathway.
    Zeng Z, Wang X, Bhardwaj SK, Zhou X, Little PJ, Quirion R, Srivastava LK, Zheng W.
    Mol Neurobiol; 2017 Jul 01; 54(5):3395-3406. PubMed ID: 27173157
    [Abstract] [Full Text] [Related]

  • 8. Pim-1 as a Therapeutic Target in Lupus Nephritis.
    Fu R, Xia Y, Li M, Mao R, Guo C, Zhou M, Tan H, Liu M, Wang S, Yang N, Zhao J.
    Arthritis Rheumatol; 2019 Aug 01; 71(8):1308-1318. PubMed ID: 30791224
    [Abstract] [Full Text] [Related]

  • 9. Complement 1q protects MRL/lpr mice against lupus nephritis via inhibiting the nuclear factor-κB pathway.
    Sun J, Guo S, Niu F, Liu D, Zhuang Y.
    Mol Med Rep; 2020 Dec 01; 22(6):5436-5443. PubMed ID: 33173997
    [Abstract] [Full Text] [Related]

  • 10. BTK inhibition ameliorates kidney disease in spontaneous lupus nephritis.
    Chalmers SA, Glynn E, Garcia SJ, Panzenbeck M, Pelletier J, Dimock J, Seccareccia E, Bosanac T, Khalil S, Harcken C, Webb D, Nabozny G, Fine JS, Souza D, Klein E, Herlitz L, Ramanujam M, Putterman C.
    Clin Immunol; 2018 Dec 01; 197():205-218. PubMed ID: 30339790
    [Abstract] [Full Text] [Related]

  • 11. Phosphoinositide 3-kinase/protein kinase B/periostin mediated platelet-derived growth factor-induced cell proliferation and extracellular matrix production in lupus nephritis.
    Zhao X, Hao J, Duan H, Rong Z, Li F.
    Exp Biol Med (Maywood); 2017 Jan 01; 242(2):160-168. PubMed ID: 27590500
    [Abstract] [Full Text] [Related]

  • 12. ALW peptide ameliorates lupus nephritis in MRL/lpr mice.
    Wang H, Lu M, Zhai S, Wu K, Peng L, Yang J, Xia Y.
    Arthritis Res Ther; 2019 Dec 02; 21(1):261. PubMed ID: 31791413
    [Abstract] [Full Text] [Related]

  • 13. P2X7 blockade attenuates murine lupus nephritis by inhibiting activation of the NLRP3/ASC/caspase 1 pathway.
    Zhao J, Wang H, Dai C, Wang H, Zhang H, Huang Y, Wang S, Gaskin F, Yang N, Fu SM.
    Arthritis Rheum; 2013 Dec 02; 65(12):3176-85. PubMed ID: 24022661
    [Abstract] [Full Text] [Related]

  • 14. YAP1 Overexpression Is Associated with Kidney Dysfunction in Lupus Nephritis.
    Xie Y, Ruan Y, Zou H, Wang Y, Wu X, Li X, Lai J, Shi M, Xiao Y, Wang Y, Zhou Y, Guo B, Zhang F.
    Pathobiology; 2021 Dec 02; 88(6):412-423. PubMed ID: 34344015
    [Abstract] [Full Text] [Related]

  • 15. Mild hypothermia pretreatment protects against liver ischemia reperfusion injury via the PI3K/AKT/FOXO3a pathway.
    Xiao Q, Ye Q, Wang W, Xiao J, Fu B, Xia Z, Zhang X, Liu Z, Zeng X.
    Mol Med Rep; 2017 Nov 02; 16(5):7520-7526. PubMed ID: 28944825
    [Abstract] [Full Text] [Related]

  • 16. 1,25-dihydroxyvitamin D3 ameliorates lupus nephritis through inhibiting the NF-κB and MAPK signalling pathways in MRL/lpr mice.
    Li X, Liu J, Zhao Y, Xu N, Lv E, Ci C, Li X.
    BMC Nephrol; 2022 Jul 08; 23(1):243. PubMed ID: 35804318
    [Abstract] [Full Text] [Related]

  • 17. Elucidating the role of the FoxO3a transcription factor in the IGF-1-induced migration and invasion of uveal melanoma cancer cells.
    Yan F, Liao R, Farhan M, Wang T, Chen J, Wang Z, Little PJ, Zheng W.
    Biomed Pharmacother; 2016 Dec 08; 84():1538-1550. PubMed ID: 27881235
    [Abstract] [Full Text] [Related]

  • 18. Xenogeneic Transplantation of Human Placenta-Derived Mesenchymal Stem Cells Alleviates Renal Injury and Reduces Inflammation in a Mouse Model of Lupus Nephritis.
    Liu J, Lu X, Lou Y, Cai Y, Cui W, Wang J, Nie P, Chen L, Li B, Luo P.
    Biomed Res Int; 2019 Dec 08; 2019():9370919. PubMed ID: 30941373
    [Abstract] [Full Text] [Related]

  • 19. [Effect of acupuncture at "Zhibian" (BL 54) through "Shuidao" (ST 28) on PI3K/AKT/FOXO3a pathway in mice with poor ovarian response].
    Hao J, Wang H, Cao Y, Ji L.
    Zhongguo Zhen Jiu; 2024 Jul 12; 44(7):821-30. PubMed ID: 38986596
    [Abstract] [Full Text] [Related]

  • 20. IL-3 contributes to development of lupus nephritis in MRL/lpr mice.
    Renner K, Hermann FJ, Schmidbauer K, Talke Y, Rodriguez Gomez M, Schiechl G, Schlossmann J, Brühl H, Anders HJ, Mack M.
    Kidney Int; 2015 Nov 12; 88(5):1088-98. PubMed ID: 26131743
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.